克力托辛
中文名称 | 克力托辛 |
---|---|
中文同义词 | 克力托辛;化合物 T30969;倒垂杯伞菌素 |
英文名称 | clitocine |
英文同义词 | clitocine;b-D-RibofuranosylaMine, N-(6-aMino-5-nitro-4-pyriMidinyl)-;β-D-Ribofuranosylamine, N-(6-amino-5-nitro-4- pyrimidinyl)-;N-(6-Amino-5-nitro-4-pyrimidinyl)-beta-D-ribofuranosylamine;N-(6-Amino-5-nitro-4-pyrimidinyl)-β-D-ribofuranosylamine;N-?(6-?amino-?5-?nitro-?4-?pyrimidinyl)?-β-?D-?Ribofuranosylamine |
CAS号 | 105798-74-1 |
分子式 | C9H13N5O6 |
分子量 | 287.231 |
EINECS号 | |
相关类别 | |
Mol文件 | 105798-74-1.mol |
结构式 | ![]() |
克力托辛 性质
形态 | 固体 |
---|---|
颜色 | 白色至米白色 |
Clitocine incorporation into mRNA is required for premature stop codon readthrough activity, and the presence of clitocine at the third position of a premature stop codon is sufficient to promote robust readthrough.
Clitocine (0-0.8 μM; 24 hours) enhances TRAIL-lethality in in LS411N and SW620 cells. Clitocine (0.2μM; 36 hours) significantly potentiates TRAIL-mediated apoptosis.
Citocine (0.3-3 mg/kg; s.c.; five times per week)-induced p53 inhibits CAOV-33 p53-UAA136 tumor growth in a xenograft model.
Animal Model: | nu/nu mice (CAOV-3p53-UAA136 xenograft tumors) |
Dosage: | 0.3, 3 mg/kg (or 20 mg/kg once per week) |
Administration: | S.c.; five times per week |
Result: | CAOV-33 p53-UAA136 tumor growth was inhibited. |
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-118341 | Clitocine | 1 mg | 1818元 | |
2024/04/30 | HY-118341 | 克力托辛 Clitocine | 105798-74-1 | 5mg | 4000元 |